Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Invent Bio-Med Private Limited, is an unlisted private company incorporated on 03 May, 2005. It is classified as a private limited company and is located in , . It's authorized share capital is INR 30.00 cr and the total paid-up capital is INR 24.70 cr.
Invent Bio-Med's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2024. It's EBITDA has increased by 614.55% over the previous year.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Shyam Manglunia
Shareholder
|
00896932 | 8 years |
| Director | Amit Banwarilal Agrawal | 07587045 | 3 years |
| Director | Rajkumar Gopilal Manglunia
Shareholder
|
00248128 | 8 years |
| Director | Ronak Manglunia
Shareholder
|
07618117 | 8 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| MOHINI ORACLES PRIVATE LIMITED |
Converted to LLP
|
99.2 L | 2 | Maharashtra |
| MOHINI ORGANICS PRIVATE LIMITED |
Active
|
31.0 L | 2 | Maharashtra |
| PINKY VENTURES PRIVATE LIMITED |
Amalgamated
|
97.6 L | 1 | Maharashtra |
| MOHINI ORACLES LLP |
Active
|
1.0 L | 1 | Maharashtra |
| RAJAL BINDAL MULTISOLUTIONS PRIVATE LIMITED |
Active
|
1.0 L | 2 | |
| KRBB FOUNDATION |
Active
|
1.0 L | 1 | Maharashtra |
| ANVESHAN MULTISOLUTIONS LLP |
Active
|
10.0 L | 1 | Maharashtra |
| CREDOMON SERVICES LLP |
Active
|
1.0 L | 1 | Maharashtra |
| N R GOLD LIMITED |
Active
|
7.2 Cr | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| SHRUTI MEDI-SCIENCE PRIVATE LIMITED | Maharashtra | 1997 | ₹ 22.5 L |
Read more
The incorporation date of INVENT BIO-MED PRIVATE LIMITED is 03 May, 2005
The authorized share capital of INVENT BIO-MED PRIVATE LIMITED is INR ₹ 30.0 Cr.
The paid-up capital of INVENT BIO-MED PRIVATE LIMITED is INR ₹ 24.7 Cr.
The registered address of INVENT BIO-MED PRIVATE LIMITED is 24 1st Floor Piramal Industrial Estate, Bldg No-4 Piramal Nagar S.V. Road Goregaon (West) Mumbai - 400104, Goregaon (Mumbai), Mumbai, Goregaon West, Maharashtra, India, 400104 - 400104
The CIN number of INVENT BIO-MED PRIVATE LIMITED is U33110MH2005PTC152988.